Publicaciones en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (30)

2024

  1. Coping behaviors to reduce anxiety and depressive symptoms: A prospective repeated assessment study

    Spanish Journal of Psychiatry and Mental Health

  2. Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

    European Neuropsychopharmacology, Vol. 85, pp. 66-77

  3. Obesity and cardiovascular and renal disease. Consensus document of the Preventive Cardiology, Clinical Cardiology, and Heart Failure Associations of the Spanish Society of Cardiology

    REC: CardioClinics, Vol. 59, Núm. 3, pp. 212-224

2023

  1. Consensus document on palliative care in cardiorenal patients

    Frontiers in Cardiovascular Medicine, Vol. 10

  2. Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

    Psychiatry Research, Vol. 323

  3. Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy

    Nature communications, Vol. 14, Núm. 1, pp. 746

  4. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1

  5. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study

    European Neuropsychopharmacology, Vol. 67, pp. 53-65

  6. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

  7. Tobacco use in first-episode psychosis, a multinational EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 15, pp. 7265-7276

2022

  1. A Cohort Study in Intensive Care Units: Health Decisions Related to Blood Transfusion during the COVID-19 Pandemic

    Journal of Clinical Medicine, Vol. 11, Núm. 15

  2. A replication study of JTC bias, genetic liability for psychosis and delusional ideation

    Psychological Medicine, Vol. 52, Núm. 9, pp. 1777-1783

  3. Análisis descriptivo de los indicadores de actividad hospitalaria publicados por las consejerías de salud

    Revista espanola de salud publica, Vol. 96

  4. COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study

    Vaccines, Vol. 10, Núm. 2

  5. Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway

    Psychological Medicine, Vol. 52, Núm. 10, pp. 1910-1922

  6. Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 113

  7. Related Factors of Anemia in Critically Ill Patients: A Prospective Multicenter Study

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  8. The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

    European Neuropsychopharmacology, Vol. 63, pp. 47-59

2021

  1. A multicentre, randomised, controlled trial of a combined clinical treatment for first-episode psychosis

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 14

  2. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543